Key facts
- Notable investors include Fil Rouge Capital, Suricate Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Vilintra
- ·The full record, as it builds
Funding rounds
No funding rounds for Vilintra are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vilintra
Developer of an electronic trial management platform designed for the medical industry. The company's platform simplifies and enhances the complex workflows involved in trial management, ensuring that every step, from document generation to final archiving, helps clients seamlessly integrate, improve collaboration, and automate systems that drive productivity and ensure regulatory compliance at every trial process.
- Sector
- Healthcare
- HQ
- Zagreb, Croatia
- Founded
- 2017
- Website
- vilintra.com/
- Ownership
- Privately Held (backing)
Vilintra doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vilintra shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vilintra in its N-PORT filings yet. We sweep new filings monthly.